{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:16:33Z","timestamp":1786115793590,"version":"build-2736575974"},"reference-count":129,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dihydromyricetin (DHM), a naturally occurring flavonoid, has shown beneficial effects in preclinical models of non-alcoholic fatty liver disease (NAFLD). Nevertheless, the extent to which dose and treatment duration influence its pharmacological effects remains to be systematically evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the pharmacological effects of DHM in preclinical models of NAFLD and to further explore the potential influence of treatment dose and duration on these effects using subgroup analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Studies were identified through systematic searches of six electronic databases. Eligible animal studies were included according to predefined criteria. Risk of bias (RoB) was assessed using the SYRCLE tool. Quantitative synthesis was performed using\n                      <jats:italic>RevMan<\/jats:italic>\n                      (version 5.4). To further explore the potential influence of treatment dose and duration, three-dimensional (3D) visualization plots and radar charts were generated using\n                      <jats:italic>OriginPro 2024<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 13 studies encompassing 14 independent experiments with 316 animals were included. DHM was associated with improvements in hepatic and serum lipid profiles, liver enzyme levels, and glucose homeostasis. Heterogeneity remained high across strata despite subgroup analyses by dose and duration. Integrated 3D plots and radar charts visually illustrated these findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DHM exhibited favorable pharmacological effects in preclinical models of NAFLD, with lipid-related outcomes appearing more sensitive to dose and liver enzyme outcomes showing greater responsiveness to treatment duration. Persistent heterogeneity highlights the need for standardized experimental protocols in future preclinical research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251124831<\/jats:ext-link>\n                      , identifier CRD420251124831.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1863189","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T05:32:54Z","timestamp":1785994374000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological effects of dihydromyricetin in preclinical models of NAFLD: a systematic review and meta-analysis stratified by dose and duration"],"prefix":"10.3389","volume":"17","author":[{"given":"Le","family":"Li","sequence":"first","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Chen","sequence":"additional","affiliation":[{"name":"GCP Department, The Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Hu","sequence":"additional","affiliation":[{"name":"Administration Department, The Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangran","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxuan","family":"Dong","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianying","family":"Chang","sequence":"additional","affiliation":[{"name":"GCP Department, The Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajuan","family":"Guo","sequence":"additional","affiliation":[{"name":"Office of the Dean of Academic Affairs, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Cui","sequence":"additional","affiliation":[{"name":"GCP Department, The Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liao","sequence":"additional","affiliation":[{"name":"Center for Evidence-based Chinese Medicine, Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"103411","DOI":"10.1016\/j.jceh.2025.103411","article-title":"Management of metabolic dysfunction-associated steatotic liver disease (MASLD): facts and hopes","volume":"16","author":"Adinolfi","year":"2026","journal-title":"J. Clin. Exp. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"114068","DOI":"10.1016\/j.ejmech.2021.114068","article-title":"Quercetin derivatives: drug design, development, and biological activities, a review","volume":"229","author":"Alizadeh","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.3390\/nu16213730","article-title":"Efficacy of myricetin supplementation on glucose and lipid metabolism: a systematic review and meta-analysis of in vivo mice studies","volume":"16","author":"Babot\u0103","year":"2024","journal-title":"Nutrients"},{"key":"B5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/ptr.8404","article-title":"Effect of pomegranate peel consumption on liver enzymes, lipid profile, liver steatosis, and Hs-CRP in patients with non-alcoholic fatty liver disease: a double-blind, placebo-controlled, randomized clinical trial","volume":"39","author":"Baghdadi","year":"2025","journal-title":"Phytother. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0324483","DOI":"10.1371\/journal.pone.0324483","article-title":"Association of triglyceride glucose-body mass index (TyG-BMI) with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis","volume":"20","author":"Boushehri","year":"2025","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/apt.16262","article-title":"Cross-linkage between bacterial taxonomy and gene functions: a study of metagenome-assembled genomes of gut microbiota in adult non-alcoholic fatty liver disease","volume":"53","author":"Canivet","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2015.05.009","article-title":"Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial","volume":"99","author":"Chen","year":"2015","journal-title":"Pharmacol. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1039\/c7fo01073g","article-title":"Pretreatment with dihydroquercetin, a dietary flavonoid, protected against concanavalin A-induced immunological hepatic injury in mice and TNF-\u03b1\/ActD-induced apoptosis in HepG2 cells","volume":"9","author":"Chen","year":"2018","journal-title":"Food Funct."},{"key":"B11","doi-asserted-by":"publisher","first-page":"111927","DOI":"10.1016\/j.biopha.2021.111927","article-title":"Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease","volume":"142","author":"Chen","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jtcme.2018.06.003","article-title":"Dihydromyricetin-rich herbal mixture extracts as a potential prescription for treatment of metabolic syndrome in rats fed a high-fat diet and subacute toxicity assessment in rats","volume":"9","author":"Chien","year":"2019","journal-title":"J. Tradit. Complement. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.phymed.2018.01.026","article-title":"Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome","volume":"41","author":"Ding","year":"2018","journal-title":"Phytomedicine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12933-023-02024-x","article-title":"FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus","volume":"22","author":"Duan","year":"2023","journal-title":"Cardiovasc Diabetol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"103025","DOI":"10.1016\/j.ctim.2024.103025","article-title":"Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: a systematic review and meta-analysis of randomized clinical trials","volume":"80","author":"Ebrahimzadeh","year":"2024","journal-title":"Complement. Ther. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1021\/acs.jafc.7b01155","article-title":"Tissue distribution, excretion, and metabolic profile of dihydromyricetin, a flavonoid from Vine tea (Ampelopsis grossedentata) after oral administration in rats","volume":"65","author":"Fan","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"eabo4474","DOI":"10.1126\/scitranslmed.abo4474","article-title":"Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease","volume":"14","author":"Fujiwara","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"175325","DOI":"10.1016\/j.ejphar.2022.175325","article-title":"Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease","volume":"935","author":"Gong","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/ph18091310","article-title":"Antidiabetic activity of silver nanoparticles biosynthesized with Stenocereus queretaroensis flower extract","volume":"18","author":"Gonz\u00e1LEZ-Garibay","year":"2025","journal-title":"Pharm. (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3892\/mmr.2018.9783","article-title":"Protective effect of dihydromyricetin revents fatty liver through nuclear factor-\u03baB\/p53\/B-cell lymphoma 2-associated X protein signaling pathways in a rat model","volume":"19","author":"Guo","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"155505","DOI":"10.1016\/j.phymed.2024.155505","article-title":"A promising therapy for fatty liver disease: PCSK9 inhibitors","volume":"128","author":"Han","year":"2024","journal-title":"Phytomedicine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1488003","DOI":"10.3389\/fphar.2024.1488003","article-title":"Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems","volume":"15","author":"He","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"13955","DOI":"10.1021\/acsomega.0c01222","article-title":"New method for extracting and purifying dihydromyricetin from Ampelopsis grossedentata","volume":"5","author":"Hu","year":"2020","journal-title":"ACS Omega"},{"key":"B28","doi-asserted-by":"publisher","first-page":"103270","DOI":"10.1016\/j.psj.2023.103270","article-title":"Dietary bile acids supplementation improves the growth performance and alleviates fatty liver in broilers fed a high-fat diet via improving the gut microbiota","volume":"103","author":"Hu","year":"2024","journal-title":"Poult. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1055\/a-1930-6658","article-title":"Shared mechanisms between cardiovascular disease and NAFLD","volume":"42","author":"Huang","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"119834","DOI":"10.1016\/j.jep.2025.119834","article-title":"Scutellariae radix and coptidis rhizoma improve NAFLD via regulation of SIRT6\/ACSL5 pathway and SCD1","volume":"348","author":"Jiang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.4014\/jmb.2406.06048","article-title":"Dihydromyricetin alleviates non-alcoholic fatty liver disease by modulating gut microbiota and inflammatory signaling pathways","volume":"34","author":"Kang","year":"2024","journal-title":"J. Microbiol. Biotechnol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"103174","DOI":"10.1016\/j.ctim.2025.103174","article-title":"Effects of Black seed (Nigella sativa L.) on cardiometabolic indices in type 2 diabetic patients: a systematic review and meta-analysis of RCTs","volume":"90","author":"Karimi","year":"2025","journal-title":"Complement. Ther. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: an update","volume":"65","author":"Katsiki","year":"2016","journal-title":"Metabolism"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e076388","DOI":"10.1136\/bmj-2023-076388","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study","volume":"384","author":"Kim","year":"2024","journal-title":"Bmj"},{"key":"B36","doi-asserted-by":"publisher","first-page":"113869","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell."},{"key":"B38","doi-asserted-by":"publisher","first-page":"36184","DOI":"10.1038\/srep36184","article-title":"Metabolomics reveals the protective of dihydromyricetin on glucose homeostasis by enhancing insulin sensitivity","volume":"6","author":"Le","year":"2016","journal-title":"Sci. Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3389\/fphar.2020.00662","article-title":"Dihydroquercetin activates AMPK\/Nrf2\/HO-1 signaling in macrophages and attenuates inflammation in LPS-induced endotoxemic mice","volume":"11","author":"Lei","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12870-020-2324-7","article-title":"Annotation of genes involved in high level of dihydromyricetin production in Vine tea (Ampelopsis grossedentata) by transcriptome analysis","volume":"20","author":"Li","year":"2020","journal-title":"BMC Plant Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"154348","DOI":"10.1016\/j.phymed.2022.154348","article-title":"Effective dose\/duration of natural flavonoid quercetin for treatment of diabetic nephropathy: a systematic review and meta-analysis of rodent data","volume":"105","author":"Li","year":"2022","journal-title":"Phytomedicine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1152\/physiol.00013.2023","article-title":"NAFLD: an emerging causal factor for cardiovascular disease","volume":"38","author":"Li","year":"2023","journal-title":"Physiol. (Bethesda)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/pharmaceutics16101303","article-title":"Stiff-soft hybrid biomimetic nano-emulsion for targeted liver delivery and treatment of early nonalcoholic fatty liver disease","volume":"16","author":"Li","year":"","journal-title":"Pharmaceutics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.aohep.2023.101174","article-title":"Administration of silymarin in NAFLD\/NASH: a systematic review and meta-analysis","volume":"29","author":"Li","year":"","journal-title":"Ann. Hepatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"155241","DOI":"10.1016\/j.phymed.2023.155241","article-title":"Effects of curcumin on non-alcoholic fatty liver disease: a scientific metrogy study","volume":"123","author":"Li","year":"","journal-title":"Phytomedicine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e0345297","DOI":"10.1371\/journal.pone.0345297","article-title":"The association between dietary inflammatory index and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"21","author":"Lin","year":"2026","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.3969\/j.issn.1001-1528.2017.12.002","article-title":"Protective effects and mechanism of dihydromyricetin on non-alcoholic fatty liver disease in ApoE-\/- mice","volume":"39","author":"Liu","year":"2017","journal-title":"Chin. Tradit. Pat. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"9570004","DOI":"10.26599\/ecmta.2025.9570004","article-title":"The future of evidence-based medicine for traditional Chinese medicine and health technology assessment","volume":"1","author":"Liu","year":"2025","journal-title":"Evidence-Based Chin. Med. Technol. Assess."},{"key":"B49","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.tifs.2019.07.038","article-title":"Dihydromyricetin: a review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability","volume":"91","author":"Liu","year":"2019","journal-title":"Trends Food Sci. Technol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"153894","DOI":"10.1016\/j.phymed.2021.153894","article-title":"Dihydroquercetin suppresses cigarette smoke induced ferroptosis in the pathogenesis of chronic obstructive pulmonary disease by activating Nrf2-mediated pathway","volume":"96","author":"Liu","year":"2022","journal-title":"Phytomedicine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"5029934","DOI":"10.1155\/2023\/5029934","article-title":"Dihydromyricetin alleviates nonalcoholic fatty liver disease and its associated metabolic syndrome by inhibiting endoplasmic reticulum stress in LDLR-\/- mice fed with a high-fat and high-fructose diet","volume":"2023","author":"Liu","year":"","journal-title":"J. Clin. Pharm. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"101926","DOI":"10.1016\/j.mcp.2023.101926","article-title":"A network pharmacology-based approach to explore the effect of dihydromyricetin on non-alcoholic fatty liver rats via regulating PPARG and CASP3","volume":"71","author":"Liu","year":"","journal-title":"Mol. Cell. Probes"},{"key":"B53","doi-asserted-by":"publisher","first-page":"101049","DOI":"10.1016\/j.ajpc.2025.101049","article-title":"Prevalence and long-term outcomes of NAFLD and cardiovascular-kidney-metabolic health in the United States","volume":"23","author":"Liu","year":"2025","journal-title":"Am. J. Prev. Cardiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"Cd011640","DOI":"10.1002\/14651858.CD011640.pub2","article-title":"Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis","volume":"3","author":"Lombardi","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J. Hepatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"7956","DOI":"10.3390\/molecules28247956","article-title":"Chemical constituents and \u03b1-Glucosidase inhibitory, antioxidant and hepatoprotective activities of Ampelopsis grossedentata","volume":"28","author":"Luo","year":"2023","journal-title":"Molecules"},{"key":"B57","first-page":"17","article-title":"Relationship of Mitochondrial fusion\/fission Genes Withdihydromyricetin Inhibiting Liver Fat Accumulation in high-fat Fed Mice","volume":"40","author":"Ma","year":"","journal-title":"J. Army Med. Univ."},{"key":"B58","first-page":"1956","article-title":"Dihydromyricetin Improves Rhythm Disorder in Expressionof Liver Circadian Clock Genes in Non-alcoholic Fatty Liver Mice","volume":"40","author":"Ma","year":"","journal-title":"J. Army Med. Univ."},{"key":"B59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/antiox11010091","article-title":"Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease","volume":"11","author":"Ma","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12944-023-01871-7","article-title":"Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora","volume":"22","author":"Miao","year":"2023","journal-title":"Lipids Health Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"54","DOI":"10.20524\/aog.2026.1019","article-title":"Dietary supplement based on dihydromyricetin in metabolic dysfunction-associated steatotic liver disease: a double-blind, placebo-controlled, randomized clinical trial","volume":"39","author":"Michailidou","year":"2026","journal-title":"Ann. Gastroenterol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.3390\/nu15183987","article-title":"Dietary patterns, foods, and nutrients to ameliorate non-alcoholic fatty liver disease: a scoping review","volume":"15","author":"Montemayor","year":"2023","journal-title":"Nutrients"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1002\/ptr.8463","article-title":"Unlocking the therapeutic potential of autophagy modulation by natural products in tackling non-alcoholic fatty liver disease","volume":"39","author":"Niazpour","year":"2025","journal-title":"Phytother. Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"954869","DOI":"10.3389\/fimmu.2022.954869","article-title":"The immune response as a therapeutic target in non-alcoholic fatty liver disease","volume":"13","author":"Ortiz-L\u00f3PEZ","year":"2022","journal-title":"Front. Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e0251","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol. Commun."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie Du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.11.037","article-title":"Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation","volume":"102","author":"Porras","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"6545","DOI":"10.3390\/molecules27196545","article-title":"Quercetin: its antioxidant mechanism, antibacterial properties and potential application in prevention and control of toxipathy","volume":"27","author":"Qi","year":"2022","journal-title":"Molecules"},{"key":"B70","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.3390\/ijms25105255","article-title":"Silver nanoparticles encapped by dihydromyricetin: optimization of green synthesis, characterization, toxicity, and Anti-MRSA infection activities for zebrafish (Danio rerio)","volume":"25","author":"Qi","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"117810","DOI":"10.1016\/j.jep.2024.117810","article-title":"The effect of Vine tea (Ampelopsis grossedentata) extract on fatigue alleviation via improving muscle mass","volume":"325","author":"Qi","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"150961","DOI":"10.1016\/j.ijbiomac.2026.150961","article-title":"From poor solubility to precision delivery: zein-\u03ba-Carrageenan nanovehicles unlock dihydromyricetin's bioactive potential","volume":"350","author":"Ren","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"9570016","DOI":"10.26599\/ecmta.2025.9570016","article-title":"What evidence is good enough?","volume":"1","author":"Robinson","year":"2025","journal-title":"Evidence-Based Chin. Med. Technol. Assess."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1007\/s11010-026-05549-3","article-title":"Flavonoids as functional food-derived modulators of the gut microbiota-NF-\u03baB axis in metabolic dysfunction-associated steatotic liver disease","volume":"481","author":"Saikia","year":"2026","journal-title":"Mol. Cell. Biochem"},{"key":"B75","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e47913","DOI":"10.1097\/MD.0000000000047913","article-title":"Epidemiological trends of NASH-Related liver cancer in young and middle-aged populations: a global disease burden analysis from 1990 to 2021","volume":"105","author":"Shang","year":"2026","journal-title":"Med. Baltim."},{"key":"B77","doi-asserted-by":"publisher","first-page":"132531","DOI":"10.1016\/j.foodchem.2022.132531","article-title":"Plant flavonoids: classification, distribution, biosynthesis, and antioxidant activity","volume":"383","author":"Shen","year":"2022","journal-title":"Food Chem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"8663","DOI":"10.3390\/ijms24108663","article-title":"Consideration for flavonoid-containing dietary supplements to tackle deficiency and optimize health","volume":"24","author":"Solnier","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"598","DOI":"10.13325\/j.cnki.acta.nutr.sin.2022.06.012","article-title":"Effects of dihydromyricetin on non-alcoholic fatty liver disease and gut microbiota in diabetic mice","volume":"44","author":"Song","year":"2022","journal-title":"Acta Nutr. Sin."},{"key":"B80","doi-asserted-by":"publisher","first-page":"794563","DOI":"10.3389\/fphar.2021.794563","article-title":"Mechanism of dihydromyricetin on inflammatory diseases","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1005312","DOI":"10.3389\/fphar.2022.1005312","article-title":"Natural flavonoids: potential therapeutic strategies for non-alcoholic fatty liver disease","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S2468-1253(23)00159-0","article-title":"NASH drug treatment development: challenges and lessons","volume":"8","author":"Tilg","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"172888","DOI":"10.1016\/j.ejphar.2019.172888","article-title":"Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases","volume":"870","author":"Tong","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"112771","DOI":"10.1016\/j.biopha.2022.112771","article-title":"Recent update on application of dihydromyricetin in metabolic related diseases","volume":"148","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1216907","DOI":"10.3389\/fendo.2023.1216907","article-title":"Research progress of dihydromyricetin in the treatment of diabetes mellitus","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40104-024-01071-y","article-title":"Dietary bile acids supplementation decreases hepatic fat deposition with the involvement of altered gut microbiota and liver bile acids profile in broiler chickens","volume":"15","author":"Wang","year":"2024","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"Cd015524","DOI":"10.1002\/14651858.CD015524.pub2","article-title":"Silymarin for adults with metabolic dysfunction-associated steatotic liver disease","volume":"6","author":"Wang","year":"","journal-title":"Cochrane Database Syst. Rev."},{"key":"B90","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.aninu.2024.10.002","article-title":"Dihydroquercetin attenuated prevotella copri-caused intestinal injury by modulating gut microbiota and bile acids in weaned piglets","volume":"20","author":"Wang","year":"","journal-title":"Anim. Nutr."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1691796","DOI":"10.3389\/fphar.2025.1691796","article-title":"Preclinical research of dihydromyricetin for fibrotic diseases","volume":"16","author":"Wang","year":"","journal-title":"Front. Pharmacol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1582861","DOI":"10.3389\/fnut.2025.1582861","article-title":"Efficacy of dietary polyphenol supplement in patients with non-alcoholic fatty liver disease: a network meta-analysis","volume":"12","author":"Wang","year":"","journal-title":"Front. Nutr."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.3390\/molecules29153537","article-title":"Mechanism of action of dihydroquercetin in the prevention and therapy of experimental liver injury","volume":"29","author":"Wei","year":"2024","journal-title":"Molecules"},{"key":"B94","doi-asserted-by":"publisher","first-page":"156317","DOI":"10.1016\/j.phymed.2024.156317","article-title":"Asiaticoside alleviated NAFLD by activating Nrf2 and inhibiting the NF-\u03baB pathway","volume":"136","author":"Wei","year":"2025","journal-title":"Phytomedicine"},{"key":"B95","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejphar.2012.03.035","article-title":"Dihydroquercetin: more than just an impurity?","volume":"684","author":"Weidmann","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jhep.2022.03.015","article-title":"Unique molecular characteristics of NAFLD-Associated liver cancer accentuate \u03b2-catenin\/TNFRSF19-mediated immune evasion","volume":"77","author":"Wong","year":"2022","journal-title":"J. Hepatol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"7145","DOI":"10.3390\/molecules28207145","article-title":"China medicinal plants of the ampelopsis grossedentata-A review of their botanical characteristics, use, phytochemistry, active pharmacological components, and toxicology","volume":"28","author":"Wu","year":"2023","journal-title":"Molecules"},{"key":"B99","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.lfs.2016.06.001","article-title":"Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress","volume":"157","author":"Xie","year":"2016","journal-title":"Life Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/antiox8080295","article-title":"Antioxidant properties of a traditional Vine tea, Ampelopsis grossedentata","volume":"8","author":"Xie","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"156385","DOI":"10.1016\/j.phymed.2025.156385","article-title":"Protective effect of puerarin in diabetic nephropathy: a systematic review and meta-analysis of animal studies","volume":"138","author":"Xu","year":"2025","journal-title":"Phytomedicine"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e47035","DOI":"10.1097\/MD.0000000000047035","article-title":"Exploring the pathogenesis of nonalcoholic fatty liver disease complicated by atherosclerosis via bioinformatics","volume":"105","author":"Yan","year":"2026","journal-title":"Med. Baltim."},{"key":"B103","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ptr.6486","article-title":"Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in Db\/Db mice","volume":"33","author":"Yang","year":"2019","journal-title":"Phytother. Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"949746","DOI":"10.3389\/fimmu.2022.949746","article-title":"Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"118354","DOI":"10.1016\/j.jep.2024.118354","article-title":"Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD","volume":"332","author":"Yang","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"155834","DOI":"10.1016\/j.phymed.2024.155834","article-title":"Integrated bioinformatics and multiomics reveal liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota","volume":"132","author":"Yang","year":"","journal-title":"Phytomedicine"},{"key":"B107","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-024-05060-7","article-title":"Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK\/PGC-1\u03b1 and PPAR\u03b1-mediated autophagy pathway","volume":"22","author":"Yang","year":"","journal-title":"J. Transl. Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1208\/s12249-021-01983-2","article-title":"Self-assembled micelles improve the oral bioavailability of dihydromyricetin and anti-acute alcoholism activity","volume":"22","author":"Ye","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"B109","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"15596","DOI":"10.1038\/s41598-021-95071-x","article-title":"Exploring the genes involved in biosynthesis of dihydroquercetin and dihydromyricetin in Ampelopsis grossedentata","volume":"11","author":"Yu","year":"2021","journal-title":"Sci. Rep."},{"key":"B111","doi-asserted-by":"publisher","first-page":"6491771","DOI":"10.1155\/2022\/6491771","article-title":"Effect of dihydroquercetin on energy metabolism in LPS-induced inflammatory mice","volume":"2022","author":"Yu","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00253-017-8686-6","article-title":"Dihydroquercetin ameliorated acetaminophen-induced hepatic cytotoxicity via activating JAK2\/STAT3 pathway and autophagy","volume":"102","author":"Zai","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/ars.2017.7172","article-title":"Dihydromyricetin ameliorates nonalcoholic fatty liver disease by improving mitochondrial respiratory capacity and redox homeostasis through modulation of SIRT3 signaling","volume":"30","author":"Zeng","year":"2019","journal-title":"Antioxid. Redox Signal"},{"key":"B114","doi-asserted-by":"publisher","first-page":"113927","DOI":"10.1016\/j.bcp.2020.113927","article-title":"Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin","volume":"175","author":"Zeng","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"116788","DOI":"10.1016\/j.jep.2023.116788","article-title":"A comprehensive review of Vine tea: origin, research on materia medica, phytochemistry and pharmacology","volume":"317","author":"Zeng","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"155533","DOI":"10.1016\/j.phymed.2024.155533","article-title":"Dihydroquercetin improves experimental acute liver failure by targeting ferroptosis and mitochondria-mediated apoptosis through the SIRT1\/p53 axis","volume":"128","author":"Zeng","year":"2024","journal-title":"Phytomedicine"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3389\/fphar.2018.01204","article-title":"Recent update on the pharmacological effects and mechanisms of dihydromyricetin","volume":"9","author":"Zhang","year":"","journal-title":"Front. Pharmacol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1021\/acs.jafc.8b00944","article-title":"Amelioration of alcoholic liver steatosis by dihydroquercetin through the modulation of AMPK-dependent lipogenesis mediated by P2X7R-NLRP3-Inflammasome activation","volume":"66","author":"Zhang","year":"","journal-title":"J. Agric. Food Chem."},{"key":"B119","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jpha.2020.10.002","article-title":"Recent advances in research on Vine tea, a potential and functional herbal tea with dihydromyricetin and myricetin as major bioactive compounds","volume":"11","author":"Zhang","year":"2021","journal-title":"J. Pharm. Anal."},{"key":"B120","doi-asserted-by":"publisher","first-page":"113727","DOI":"10.1016\/j.biopha.2022.113727","article-title":"Dihydroquercetin composite nanofibrous membrane prevents UVA radiation-mediated inflammation, apoptosis and oxidative stress by modulating MAPKs\/Nrf2 signaling in human epidermal keratinocytes","volume":"155","author":"Zhang","year":"","journal-title":"Biomed. Pharmacother."},{"key":"B121","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1080\/10717544.2022.2125601","article-title":"Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges","volume":"29","author":"Zhang","year":"","journal-title":"Drug Deliv."},{"key":"B122","doi-asserted-by":"publisher","first-page":"11124","DOI":"10.1080\/10408398.2023.2232880","article-title":"Food matrix-flavonoid interactions and their effect on bioavailability","volume":"64","author":"Zhang","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1618623","DOI":"10.3389\/fphar.2025.1618623","article-title":"Pharmacological mechanisms and potential clinical applications of dihydromyricetin in neurological disorders","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"783886","DOI":"10.3389\/fphar.2021.783886","article-title":"Dihydromyricetin reverses thioacetamide-induced liver fibrosis through inhibiting NF-\u03baB-Mediated inflammation and TGF-\u03b21-Regulated of PI3K\/Akt signaling pathway","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.bbadis.2017.03.019","article-title":"Dihydromyricetin prevents obesity-induced slow-twitch-fiber reduction partially via FLCN\/FNIP1\/AMPK pathway","volume":"1863","author":"Zhou","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.3390\/nu13092917","article-title":"Systematic review and meta-analysis on the effects of astaxanthin on human skin ageing","volume":"13","author":"Zhou","year":"","journal-title":"Nutrients"},{"key":"B127","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12986-021-00589-6","article-title":"Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect","volume":"18","author":"Zhou","year":"","journal-title":"Nutr. Metab. (Lond)"},{"key":"B128","doi-asserted-by":"publisher","first-page":"887263","DOI":"10.3389\/fphar.2022.887263","article-title":"Dihydromyricetin-encapsulated liposomes inhibit exhaustive exercise-induced liver inflammation by orchestrating M1\/M2 macrophage polarization","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13287-022-03231-1","article-title":"Neural stem\/progenitor cell therapy for alzheimer disease in preclinical rodent models: a systematic review and meta-analysis","volume":"14","author":"Zhou","year":"2023","journal-title":"Stem Cell. Res. Ther."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.3969\/j.issn.1001-1978.2018.11.026","article-title":"Effect of dihydromyricetin on reverse cholesterol transport in high-fat feeding ApoE-\/- mice","volume":"34","author":"Zhu","year":"2018","journal-title":"Chin. Pharmacol. Bull."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1863189\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T05:33:02Z","timestamp":1785994382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1863189\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":129,"alternative-id":["10.3389\/fphar.2026.1863189"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1863189","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"article-number":"1863189"}}